Zobrazeno 1 - 10
of 6 744
pro vyhledávání: '"In‐Ho Song"'
Autor:
Filip Van den Bosch, Atul Deodhar, Denis Poddubnyy, Walter P. Maksymowych, Désirée van derHeijde, Tae‐Hwan Kim, Mitsumasa Kishimoto, Xenofon Baraliakos, Yihan Li, Kristin D'Silva, Peter Wung, In‐Ho Song
Publikováno v:
ACR Open Rheumatology, Vol 6, Iss 8, Pp 470-480 (2024)
Objective Upadacitinib improved the signs and symptoms of non‐radiographic axial spondyloarthritis (nr‐axSpA) versus placebo over 14 weeks in the primary analysis of the SELECT‐AXIS 2 nr‐axSpA study. Here, we evaluated the efficacy and safety
Externí odkaz:
https://doaj.org/article/db103b5345e54f818689f724ae2c5979
Autor:
In-Ho Song, Hyun-Woong Kim, Jong-Sung Park, Seung-Myung Park, Jae-Yun Lee, Eun-Jung Nam, Yong-Jae Lim, Jung-Min Park, Myung-Soo Yoo, Seog-Yeon Cho, Hye-Jung Shin
Publikováno v:
Atmosphere, Vol 15, Iss 9, p 1120 (2024)
In this study, the characteristics of ammonia and their effects on secondary particulate matter (PM) formation were analyzed by region in Korea in 2020. The NH3 concentration was high in GJ (11.4 ppb), a neighboring agricultural area, followed by DJ
Externí odkaz:
https://doaj.org/article/43f21bf37e454f9da2aa64994167804c
Autor:
Xenofon Baraliakos, Désirée van der Heijde, Joachim Sieper, Robert D. Inman, Hideto Kameda, Yihan Li, Xianwei Bu, Anna Shmagel, Peter Wung, In-Ho Song, Atul Deodhar
Publikováno v:
Arthritis Research & Therapy, Vol 25, Iss 1, Pp 1-11 (2023)
Abstract Background Upadacitinib, a Janus kinase inhibitor, has demonstrated efficacy and an acceptable safety profile in patients with ankylosing spondylitis (AS) in the phase III SELECT-AXIS programs. We report the 1-year efficacy and safety in pat
Externí odkaz:
https://doaj.org/article/7f4ff86d151f43cca82d9576ff248e5b
Autor:
Sumit Bhatnagar, Doerthe Eckert, Sven Stodtmann, In‐Ho Song, Peter Wung, Wei Liu, Mohamed‐Eslam F. Mohamed
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 2, Pp n/a-n/a (2024)
Abstract Upadacitinib is an orally administered, selective, Janus kinase inhibitor that is approved for several auto‐immune conditions, such as axial spondyloarthritis, an inflammatory rheumatic disease that includes ankylosing spondylitis (AS) and
Externí odkaz:
https://doaj.org/article/0555cf245c5a4ec08279231b06dd5a7d
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 171, Iss , Pp 116106- (2024)
In this study, a series of 2-Aryl-1H-benzo[d]imidazole derivatives were developed to target intra- and extracellular microtubule networks. Compounds O-7 and O-10 showed impressive anti-proliferative activity across various tested cell lines, demonstr
Externí odkaz:
https://doaj.org/article/7ec85bf257ed44e39afc68f1c7df4d24
Autor:
Xenofon Baraliakos, Roberto Ranza, Andrew Östör, Francesco Ciccia, Laura C. Coates, Simona Rednic, Jessica A. Walsh, Kevin Douglas, Tianming Gao, Koji Kato, In-Ho Song, Fabiana Ganz, Atul Deodhar
Publikováno v:
Arthritis Research & Therapy, Vol 25, Iss 1, Pp 1-13 (2023)
Abstract Background The objective of this post-hoc analysis was to assess the efficacy and safety of upadacitinib in psoriatic arthritis (PsA) patients with axial involvement. Methods Post-hoc analysis of SELECT-PsA 1 and SELECT-PsA 2 in patients ran
Externí odkaz:
https://doaj.org/article/90d18e6abacf401699f4e7aeeb68ccd1
Autor:
Seung-Myung Park, Jong Sung Park, In-Ho Song, Jeonghwan Kim, Hyun Woong Kim, Jaeyun Lee, Jung Min Park, Jeong-ho Kim, Yongjoo Choi, Hye Jung Shin, Joon Young Ahn, Yu Woon Jang, Taehyoung Lee, Gangwoong Lee
Publikováno v:
Atmosphere, Vol 15, Iss 3, p 320 (2024)
We performed continuous long-term measurements of PM2.5 mass, comprehensive chemical composition, and optical properties, including scattering and absorption coefficients, from March 2011 to December 2020 at the Metropolitan Air Quality Research Cent
Externí odkaz:
https://doaj.org/article/c86f5482bdea494ab829a311841d9d0f
Autor:
Victoria Navarro-Compán, Xenofon Baraliakos, Marina Magrey, Andrew Östör, Christopher D. Saffore, Manish Mittal, In-Ho Song, Fabiana Ganz, Jayne Stigler, Atul Deodhar
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 3, Pp 679-691 (2023)
Abstract Introduction Patients with ankylosing spondylitis (AS) have significant unmet treatment needs, despite advancements in biologic therapies. This study evaluated the impact of upadacitinib on clinically meaningful improvement in patient-report
Externí odkaz:
https://doaj.org/article/4c4e65cdcd924c5cbdacdf4e4e9d1654
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 164, Iss , Pp 114977- (2023)
In recent years, microtubule-targeting agents (MTAs) have gained considerable interest in developing novel small-molecule anticancer drugs. MTAs demonstrate anticancer activity either as microtubule-stabilizing agents (paclitaxel) or microtubule-dest
Externí odkaz:
https://doaj.org/article/17851e83023d40559234030a24aa1b8d
Autor:
Désirée van der Heijde, Filip van den Bosch, Atul Deodhar, Joachim Sieper, Bernard Combe, Walter P Maksymowych, In-Ho Song, Tae-Hwan Kim, Mitsumasa Kishimoto, Yuanyuan Duan, Yunxia Sui, Andrew J Östör, Peter K Wung
Publikováno v:
RMD Open, Vol 8, Iss 2 (2022)
Introduction Long-term safety and efficacy of upadacitinib in patients with active ankylosing spondylitis (AS) has not been previously reported.Methods In SELECT-AXIS 1, patients receiving placebo were switched to upadacitinib 15 mg once daily at wee
Externí odkaz:
https://doaj.org/article/70da74d6d0eb473ab12c42387a181ffd